Senior Director, Commercial Launch Leader

Senior Director, Commercial Launch Leader

There are more than 9 million immunocompromised people in the United States. Almost half a million of those represent a population that are moderately to severely immunocompromised and at highest risk for severe COVID-19, including stem cell and solid organ transplant patients as well as those with hematologic cancers.

At Invivyd, Inc., we take those numbers very seriously and we come to work each day on a mission to deliver protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies.

In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. In October 2025, the FDA cleared the company's Investigational New Drug (IND) application and provided feedback to advance the company's REVOLUTION clinical program, Invivyd's development program for VYD2311, a vaccine alternative monoclonal antibody candidate for the prevention of COVID.

Join an incredible team of people who thrive in a start-up environment, embrace a shared sense of ownership, have a passion for impacting patients and their families, think boldly and creatively, take targeted risks, are unafraid of failure, and welcome change as a positive catalyst to new opportunities and growth.

Be part of making a difference. Be part of Invivyd.

Location : Northeast Preferred

We are seeking a strategic, enterprise-minded commercial leader to drive the success of VYD 2311 product launch. This role will work in conjunction with the commercial leadership team to define the US launch strategy and oversee the tactical activities for a highly successful outcome. As a central influencer within the organization, you will shape both near-term launch excellence and long-term product lifecycle value.

Reporting into the Commercial Strategies & Operations team, you will chair cross-functional commercialization governance, serve as the lead commercial voice in VYD2311 launch decisions, and coordinate integrated execution across geographies and functions. This is a high-impact role with significant visibility to senior leadership and external stakeholders.

Responsibilities :

• Lead, in coordination with commercial functional leaders, end-to-end product launch strategy and tactical coordination through commercialization.
• Work with other commercial leadership to develop and refine Target Product Profiles (TPPs), value propositions, market segmentation, and differentiation strategies based on evolving science, unmet needs, and competitive dynamics
• Lead development of Asset Launch playbook to support follow on launches
• Evaluate global pricing and reimbursement dynamics and incorporate into value strategies
• Drive scenario planning to de-risk commercialization and maximize asset value
• Act as the primary global commercial point of contact across R&D, Clinical, Regulatory as it pertains to VYD2311 commercial launch readiness
• Ensure adherence to global regulatory, compliance, and ethical standards
• Lead, inspire, and develop a high-performing cross-functional commercialization team
• Manage launch budgets and allocate resources against prioritized value drivers
• Work effectively in a matrixed environment, influencing without formal authority

Requirements :